Rhino Biotech Limited's total assets for Q were $647.90K, a decrease of -37.63% from the previous quarter. RBRXF total liabilities were $20.22K for the fiscal quarter, a 20.16% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.